Monday, 24 April 2017
Latest news
Main » What are analysts Suggestions on: CVS Health Corporation (NYSE:CVS)

What are analysts Suggestions on: CVS Health Corporation (NYSE:CVS)

13 December 2016
What are analysts Suggestions on: CVS Health Corporation (NYSE:CVS)

The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. For the next 5 years, CVS Health Corporation is expecting Growth of 10.87% per annum, whereas in the past 5 years the growth was 14.4% per annum.

CVS Health Corporation (NYSE:CVS) stock is presently standing at about $80.13 and lots of equity research firms seem to have a target price set on the stock.

Historically, if we look at price target revisions, three weeks ago CVS Health Corp (NYSE:CVS)'s price target was revised on 11/14/16 by the analysts, however the bullish price estimates of the stock set at $122 while the bearish estimates kept at $84 over the next one year. CVS Health Corp (NYSE:CVS)'s shares are now trading -24.18% away from the 52-week high price of $105.68 and +15.63% far from the 52-week low price of $69.30. Its EVP & CIO GOLD STEPHEN J sold 9,798 company shares for $1028000.79, in a transaction on 2016-05-05. The stock traded with the volume of 6.72 Million shares yesterday. The difference between the actual and expected EPS is $0.07 a share with a surprise factor of 4.5%. The stock's current distance from 20-Day Simple Moving Average (SMA20) is 5.45% where SMA50 and SMA200 are -1.78% and -13.85% respectively. Similarly, the company has Return on Assets of 5.1 percent, Return on Equity of 13.2 percent and Return on Investment of 9.4 Percent. The risk associated with the company in terms of profitability during the year 2017 has been eliminated for the most part.

CVS Health (NYSE:CVS) had its TP cut by Jefferies to $82.00 in analysts note revealed on 12 December. On 20-Jun-16 Morgan Stanley Downgrade CVS Health Corporation Stock to Equal-Weight.

This company was Initiated by Citigroup on 18-Nov-16 to Buy. Of them, 10 have a "buy", 0 suggested "sell", 5 said "hold" and 0 called "underperform" rating for the stock, according to Thomson Reuters data. According to these analysts, the Low Revenue Estimate for CVS Health Corporation is 45.83 Billion and the High Revenue Estimate is 47.61 Billion.

According to Zacks Investment Research, "CVS Health Corporation is a pharmacy innovation company". The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. CVS Health Corporation presently has a consensus rating of "Buy" and an average target price of $103.36. The median estimate represents a +7.43% increase from the last price of 57.71. Jefferies advised their investors in a research report released on Dec 12, 2016. After the day began at $147.00, the stock was seen hitting $147.00 as its intraday high price and $144.36 as its bottom price. The reported EPS for the same quarter previous year was $0.93.

The consensus recommendation for Southwest Airlines Co. 0 analysts assign "Sell" rating for the stock.

The Stock gained 0.49% and closed its last trading session at $57.71. The stock has 52-week high of $57.75 and 52-Week low of $40.26. During its last trading session, Stock traded with the total exchanged volume of 6.72 million shares. This shows a surprise factor of 15.2 percent. The performance for the year is at -13.89% and the performance (year to date) is at -16.56%.

While taking an overview of recommendation trends, the stock now has an average brokerage recommendation of 1.43. The company has an Average Rating of 1.79 based on analysts tracked by Thomson Reuters. The last closing price is down -11.29% from the 200-day moving average, compared to the S&P 500 which has decreased -0.03% over the same time.

The Company now has ROA (Return on Assets) of 10 percent, Return on Equity (ROE) of 32.2 Percent and Return on Investment (ROI) of 21.8% with Gross margin of 23 percent and Operating & Profit margin of 20.9% and 16.1% respectively.